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ABSTRACT
Objective: To assess the quality of diagnostic work-up received by patients with “possible”
polycystic ovary syndrome (PCOS).
Design: A retrospective chart review. 
Setting: A hospital based Pediatric Clinic in New York City. 
Patients: Sixty female patients aged 13-19 years, with a primary ICD-9 diagnosis of ovarian
dysfunction (256), menstrual irregularity (626), or hirsutism (704.1) were randomly selected
for evaluation. In addition, 18 patients who were assigned the same ICD-9 codes at the
Pediatric Endocrine Clinic were assessed. 
Main Outcome: Rates of assessment for diagnostic criteria of PCOS and selected co-morbidities. 
Results: Twenty-five percent (15/60) of the patients were evaluated for PCOS according to
the Rotterdam Criteria, and only 2 were evaluated for common co-morbidities associated with
PCOS. Of the 28 patients who presented with two or more signs of PCOS (menstrual irregu-
larity plus either obesity, hirsutism and/or acne), 15 were evaluated for PCOS (54%), but only
7% were assessed for common co-morbidities.
All patients referred to the Pediatric Endocrine Clinic received appropriate evaluation for
PCOS. In addition, 89% of the study group underwent further assessment for selected com-
plications of PCOS.
Conclusions: Patients presenting to an inner-city pediatric clinic with “possible” PCOS often
do not receive a complete diagnostic evaluation. In addition, those evaluated for PCOS are
often not adequately screened for the known health consequences associated with this con-
dition. These findings suggest that PCOS is under evaluated and possibly under diagnosed in
this pediatric population, which raises serious concerns regarding the potential for major long-
term public health consequences. 
Conflict of interest: None declared
INTRODUCTION
Polycystic ovary syndrome (PCOS) is a
common disorder with an estimated preva-
lence of 5-10% in women of reproductive
age.
1 The prevalence has been increasing in
the adolescent population.
2 In more than
40% of cases, PCOS is associated with obe-
sity,
3 as well as impaired glucose tolerance,
type 2 diabetes, and the metabolic syn-
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drome.
4 Furthermore, in adult female
patients it is associated with an increased
risk of endometrial cancer and is the most
common identifiable cause of female infer-
tility.
1-6 While the pathophysiology of PCOS
remains unclear, insulin resistance has been
implicated as a major causative factor.
7 In
addition to this, several genes have been
associated with this syndrome.
8
There is an increasing awareness of PCOS
among the adolescent population
9 along with
an increase in diagnosis and an increased inci-
dence of established co-morbidities such as
obesity and type 2 diabetes.
2,10 Even so, diag-
nosis in this population can often be elusive.
11
Accurate diagnosis of PCOS is of critical
importance to public health, given the chron-
ic nature of the disorder and its association
with multiple health consequences.
11
PCOS has many presentations and multiple
definitions have been suggested for this disor-
der.
8 Also, it may mimic other disorders such as
congenital adrenal hyperplasia and androgen
secreting neoplasms.
4 Given the variability of
signs, symptoms, biochemical and radiologic
features in a given individual, diagnosis of
PCOS can be easily missed. Moreover, even
when PCOS is correctly diagnosed screening
for other metabolic constellations may not be
consistently carried out. Therefore, we ana-
lyzed the quality of the evaluation process for
PCOS and associated conditions in a popula-
tion of adolescent girls presenting to urban
Pediatric and Pediatric Endocrine clinics with
the possible diagnosis of PCOS.
METHODS
Study Design and Patient Population
The study was approved by an institutio-
nal review board and a retrospective chart
review was performed. Medical records of
patients aged 13-19 years who presented in
2005-2006 with a “possible” diagnosis of
PCOS were evaluated by a single investiga-
tor (Table 1). “Possible PCOS” was defined
according to the ICD-9 codes of ovarian dys-
function (256), menstrual irregularity (626)
or hirsutism (704.1) either alone or in com-
bination. ICD-9 codes of diabetes mellitus
(250) and obesity (278) were also recorded
due to their association with PCOS. Patients
with known causes (i.e. pregnancy, malig-
nancy or congenial adrenal hyperplasia) of
these conditions were excluded. One thou-
sand forty patients with possible PCOS were
identified, and 60 were selected for analysis
by simple random sampling (i.e. 60 charts
were randomly selected from the 1040 charts
which were manually reviewed). 
A. Criteria for the diagnosis of PCOS
Each patient was evaluated for the quality
of diagnostic work-up for PCOS according to
the Rotterdam Criteria.
8 This included evalua-
tion for at least two of the following: menstru-
al irregularity, clinical or biochemical evidence
of hyperandrogenism, and ultrasonographic
(either transvaginal or transabdominal) fea-
tures suggestive of PCOS. Patients who
received at least two of these evaluations were
considered adequately evaluated for PCOS. 
B. Assessment of features associated
with PCOS
Eight specific criteria selected for their diag-
nostic and prognostic association with PCOS
were assessed. These included: menstrual
irregularities, hirsutism, ovarian ultrasound,
fasting glucose, fasting insulin, lipid profile
(HDL, LDL and triglycerides), testosterone, and
FSH to LH ratio. Patients who were tested for
all eight criteria were considered fully evaluat-
ed. Those who were tested for <8 but >2 crite-
ria were considered partially evaluated.
Evaluation in the pediatric clinic
Sixty patients were randomly selected
and studied for the quality of the diagnostic
evaluation they received for PCOS and fea-
tures associated with PCOS.
Evaluation in the subspecialty Pediatric
Endocrine Clinic
As a quality control, 18 patients who
were referred and evaluated in 2005-2006 at
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the Pediatric Endocrine clinic of the same
hospital were analyzed. These patients were
assessed according to the same criteria for
both diagnostic evaluation and associated
findings of PCOS.
RESULTS
Twenty five percent (15/60) of the
patients seen in the general pediatric clinic,
were considered to have received an ade-
quate diagnostic evaluation for PCOS accord-
ing to the Rotterdam Criteria (i.e. evaluation
for menstrual irregularity, hyper-andro-
genism or ovarian ultrasound features, Table
1, Figure 1). Of the 15 patients adequately
evaluated for PCOS, 6 (40%) fulfilled the
Rotterdam diagnostic criteria for PCOS, yet
only 3 (50%) were coded as PCOS (Table 2). 
Of the initial 60 patients, 36 had other
findings in addition to menstrual irregularity.
Of these 36 patients with additional findings,
32% were obese, 21% had acne, and 7%
were hirsute (all associated with elevated
testosterone levels and PCO appearance on
ultrasound, Figure 2), however only 15 were
evaluated for PCOS (54%), and only 7%
received evaluation addressing a selected
group of findings most commonly associat-
Table 1: Demographics of patients according to ICD-9 code. A, General Pediatric Clinic. B, Pediatric Endocrine
Clinic. ICD-9 codes: ovarian dysfunction (256), menstrual irregularity (626), hirsutism (704.1), diabetes mellitus (250)
and obesity (278).
ICD-9 Number of Mean Race
Patients Age
Hispanic Black White Pacific Islander Other
250 1 17 0 0 0 0 1
256 5 16.6 ± 0.9 5 0 0 0 0
278 19 15.8 ± 0.7 18 0 0 0 1
626 55 16.4 ± 0.9 41 8 0 3 3
704.1 4 14.0 ± 1.0 2 0 1 1 0
ICD-9 Number of Mean Race
Patients Age
Hispanic Black White Pacific Islander Other
250 1 16 0 0 0 0 1
256 4 16 ± 1.4 3 0 0 0 1
278 11 15.6 ± 0.8 10 0 0 0 1
626 14 15.9 ± 1.5 10 3 0 1 0
704.1 3 13.7 ± 1.2 2 0 1 0 0
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Figure 1: Percentage of patients (%) evaluated for PCOS
among 60 patients with “possible” PCOS. NE, patients not eval-
uated with any of the following: testosterone levels and/or
ovarian ultrasound, FSH/LH, fasting blood glucose or lipid
panel; PE, patients partially evaluated with testosterone levels
and/or ovarian ultrasound, but not FSH/LH, fasting blood glu-
cose or lipid panel; FE, patients fully evaluated with testos-
terone levels and/or ovarian ultrasound, FSH/LH, fasting blood
glucose or lipid panel.ed with PCOS (Figure 3). Furthermore, only
2 of the 6 patients with findings diagnostic
for PCOS were evaluated for selected associ-
ated medical conditions (data not shown). 
Of the 1040 patients in the original pop-
ulation identified according to the ICD-9
diagnostic codes, 18 who were referred to
the Pediatric Endocrine Clinic were included
in the analysis (Table 1). All of the referred
patients received adequate diagnostic evalu-
ation for PCOS (Figure 1, Table 2).
Moreover, the majority of these patients
(89%) were also assessed for medical condi-
tions known to be associated with PCOS
(Figure 1).
DISCUSSION
PCOS can be a diagnostic quandary for
pediatricians for many reasons. Adolescents
may not always seek medical attention for
oligo or amenorrhea,
12 and if they do, they
are often prescribed oral contraceptive pills
(OCPs) to regulate their menses without
being offered an endocrinologic evaluation.
Many of these patients will remain on OCPs
until the time of desired fertility, often many
years later, which will mask any prolonged
menstrual disturbances, as well as features
of hyperandrogenism. With these difficulties
in mind, we reviewed the data obtained
from adolescent girls presenting with a “pos-
sible” diagnosis of PCOS in an urban hospi-
tal-based clinic. We demonstrated that these
patients are not adequately evaluated for
PCOS or its associated complications.
PCOS may present in the adolescent
years,
9 but limited data are available on its
prevalence or pathophysiology specifically
for this age group.
13 Despite the paucity of
data, it is clear that PCOS confers a physi-
cal, emotional and economic burden on
Table 2: Most common ICD-9 coded diagnoses in patients with “possible” PCOS.  A, General Pediatric Clinic. B,
Pediatric Endocrine Clinic.
Menstrual Number of Number of
Number of Irregularity/Ovarian Patients Evaluated Patients with
Patients Dysfunction Hirsutism Obesity Acne for PCOS PCOS
32 X 1 0
11 X X 3 1
8X X 4 0
5X X X 3 1
3X X X 3 3
1X X 1 1
Total 60 4 19 13 15 6
Menstrual Number of Number of
Number of Irregularity/Ovarian Patients Evaluated Patients with
Patients Dysfunction Hirsutism Obesity Acne for PCOS PCOS
1X 1 0
4X X 4 3
2X X 2 1
4X X X 4 4
2X X X 2 3
3X X 3 1
2X 2 2
Total 18 5 10 6 18 14
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both adults and adolescents affected with
this condition.
4 Accurate diagnosis at a
younger age may be a key to preventing
many of the long-term health consequences
associated with this syndrome. In our pop-
ulation of patients with “possible” PCOS,
only 25% received a sufficient diagnostic
work-up for this condition. Even patients
who presented with obesity, hirsutism
and/or acne (all associated with PCOS) in
addition to menstrual irregularity as a sub-
group, were evaluated for PCOS only 50%
of the time. Of those evaluated for PCOS,
nearly half had PCOS according to diagnos-
tic criteria
8 but were not coded or treated as
such. These data indicate that nearly half of
adolescents presenting with PCOS in this
population may be missed. On the other
hand, the 25% of patients who were initial-
ly evaluated may have presented with clin-
ically more severe symptoms, and could
represent a higher proportion of actual
PCOS cases. In either case, it is likely that a
significant number of cases of PCOS in the
adolescent population are being missed.
In addition, even when patients are
assessed for PCOS in the primary care set-
ting, they are often not evaluated for known
co-morbidities. Less than 10% of patients
were tested for impaired glucose tolerance
or hyperlipidemia. Type 2 diabetes mellitus
and metabolic syndrome have been increas-
ing in both the adult and pediatric popula-
tions,
15,16 and are strongly associated with
PCOS.
17 Therefore, a missed diagnosis of
PCOS and its co-morbidities may be a
missed opportunity to halt the development
of these complications.
On the other hand, all patients evaluated
in the Pediatric Endocrine Clinic received a
full evaluation for PCOS. In a survey of pedi-
atric endocrinologists, 67% of respondents
reported that they would measure testos-
terone in a patient that presented with
oligomenorrhea alone.
14 Consistent with our
findings, these data indicate that pediatric
endocrinologists often perform a more
exhaustive work-up for PCOS than general
pediatricians. In addition, endocrinologists
and gynecologists evaluate and manage
PCOS differently.
18 In women with suspected
PCOS, endocrinologists were more likely to
evaluate androgen, lipid and glucose levels,
while gynecologists were more likely to
order ovarian ultrasounds. It is clear that
there is no consensus between pediatricians,
endocrinologists, and gynecologists regard-
ing the evaluation and management of ado-
lescents with PCOS. 
In conclusion, the present study suggests
that PCOS is being underevaluated and pos-
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Figure 2: Most common additional diagnoses according to
ICD-9 code in 60 patients with “possible” PCOS in General
Pediatric Clinic.
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Figure 3: Percentage of patients (%) with “possible” PCOS in
General Pediatric Clinic who received selected laboratory
evaluations. sibly underdiagnosed in the adolescent pop-
ulation. PCOS is associated with many health
consequences, both of immediate (poor self-
esteem, acne
9) and long-term (diabetes, heart
disease, metabolic syndrome, infertility
10)
concern. Awareness of PCOS and its diagno-
sis must be increased among physicians car-
ing for adolescent girls. A policy statement on
the diagnosis of PCOS specifically addressing
the adolescent population may be warranted
for adequate diagnosis of this disorder.
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